Netherlands· NL-4ce5c546c43a
Zypadhera 405 mg, poeder en oplosmiddel voor suspensie voor injectie, met verlengde afgifte
A olanzapine product containing olanzapinepamoatinezuur 1-water, registered in Netherlands by Cheplapharm Registration GmbH. The same ATC class is registered in 18 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Olanzapine is registered in 18 of 19 countries.
Countries holding a registration under ATC N05AH03 (olanzapine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Olanzapine · ATC N05AH03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of olanzapine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.17 in United States to $3.34 in Switzerland — a ×19 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Olanzapine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.34
- IT Italy$1.59
- FR France$0.63
- US United States$0.17 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- OLANZAPINEPAMOATINEZUUR 1-WATER
- Manufacturer
- Cheplapharm Registration GmbH
- Country
- Netherlands (NL)
- ATC code
- N05AH03
- ATC class
- Olanzapine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/08/479
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
481 interactions on record for olanzapine.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olanzapine · interactions on record
481 records
- 14 severe
- 292 moderate
- 3 minor
- 137 info
Most severe, free to view
- MetoclopramideA03FA01severe
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
35 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olanzapine in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandZYPADHERACheplapharm Registration GmbH
- FranceZYPADHERA 405 mg, poudre et solvant pour suspension injectable à libération prolongéeCHEPLAPHARM REGISTRATION (ALLEMAGNE)
- IrelandZypadhera 405 mg powder and solvent for prolonged release suspension for injectionCheplapharm Registration GmbH
- CzechiaEGOLANZAEgis Pharmaceuticals PLC, Budapešť
- United KingdomArkolamyl 10mg orodispersible tabletsViatris UK Healthcare Ltd
- United StatesolanzapineBionpharma Inc.
- SpainARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGNeuraxpharm Spain S.L.U.
- PolandAnzorinOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Aedon, Olanzapin +pharma
- Belgium · Olanzapine, Olanzapine Ab
- Bulgaria · Oлфрекс, Еголанза
- Cyprus · Bloonis, Lapozan
- Czechia · Egolanza, Nykob
- Germany · Olanzapin 1 A Pharma, Olanzapin Abz
- Denmark · Farpenta, Kynapine Odt
- Estonia · Farpenta, Olanzapin Actavis
- Spain · Arenbil, Arenbil Flas
- Finland · Olanzapin Orion, Olanzapin Ratiopharm
- France · Olanzapine Accord, Olanzapine Arrow
- United Kingdom (Northern Ireland) · Olanzapine Accord, Olanzapine Bristol Laboratories
- Greece · Bloonis, Caprilon Od
- Croatia · Olandix, Olanzalux
- Hungary · Egolanza, Olpinat
- Ireland · Olanzapine Accord, Olanzapine Accord Healthcare Ireland
- Iceland · Olanzapin Actavis, Olanzapine Teva
- Italy · Farpenta, Lazapir
- Liechtenstein · Olanzapine Teva, Olanzapine Viatris
- Lithuania · Olanzapin Actavis, Olanzapine Accord
- Luxembourg · Olanzapine Eg, Olanzapine Instant Eg
- Latvia · Olanzapine Accord
- Malta · Olancer, Olanzapine Aurobindo
- Norway · Olanzapine Accord, Olanzapine Teva
- Poland · Egolanza, Olanzapina Viatris
- Portugal · Olanzapina Alter, Olanzapina Aurobindo
- Romania · Olanzapină Arena, Olanzapina Aurobindo
- Sweden · Olanzapin Actavis, Olanzapin Sandoz
- Slovenia · Zolrix
- Slovakia · Olanzapin Actavis, Olanzapin Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0cab3ad2-bc2e-46a7-8b78-56d44334703e GET /v1/drugs/0cab3ad2-bc2e-46a7-8b78-56d44334703e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte",
"route": "Intramusculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/zypadhera-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Olanzapine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp100676",
"excipients": [
"CARMELLOSE NATRIUM (E 466)",
"GEEN HULPSTOFFEN",
"MANNITOL (D-) (E 421)",
"NATRIUMHYDROXIDE (E 524)",
"POLYSORBAAT 80 (E 433)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"OLANZAPINEPAMOATINEZUUR 1-WATER"
],
"leaflet_url": null,
"authorised_at": "2008/11/19",
"procedure_number": "EMEA/H/C/000890",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/08/479",
"additional_monitoring": "N"
}See everything about olanzapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.